Are these test results normal if you're on a GLP-1 like semaglutide or tirzepatide for long-term maintenance (not just short-term)?

Understanding Expected Lab Changes on GLP-1 Medications

When patients reach the maintenance phase after completing my The 30-Week Tirzepatide Reset protocol, their bloodwork often looks quite different from someone not using these medications. Tirzepatide and semaglutide, both GLP-1 receptor agonists, create predictable shifts that are generally considered normal when the medication is used strategically. In our clinic, we see fasting glucose drop 15-30 points, A1C fall below 5.7 in most responders, and fasting insulin often normalize under 8 μU/mL. These changes reflect restored insulin sensitivity rather than masking symptoms.

Key Markers That Shift During Long-Term Use

Liver enzymes like ALT and AST frequently decrease by 20-40% because reduced caloric intake and lower inflammation from the lectin-free diet in our protocol ease fatty liver burden. Lipid panels improve dramatically—triglycerides commonly fall below 100 mg/dL while HDL rises. However, LDL may appear elevated in some due to increased fat mobilization; this is often benign if particle size improves, which we track via advanced panels. Kidney function (eGFR) typically stays stable or improves slightly with better blood pressure control, though we monitor closely in patients over 50 with prior hypertension.

Thyroid markers deserve attention during maintenance. TSH may rise modestly as weight stabilizes, reflecting normalized hypothalamic signaling. In the book, I detail how our cycling approach—using one box of tirzepatide across three 70-day cycles—prevents receptor burnout while allowing natural hormone recovery. Gastrointestinal side effects often resolve, but nutrient labs (B12, iron, vitamin D) can dip if patients skip our targeted Drops and real-food emphasis.

When Results Signal a Need for Adjustment

Not every change is ideal. Persistent low heart rate under 50 bpm, unexplained fatigue with cortisol below 10 μg/dL, or rising CRP despite fat loss may indicate over-cycling or inadequate recovery. In The 30-Week Tirzepatide Reset, the 69 Transformation Steps guide patients through Japanese-style walking, red light therapy, and chaotic intermittent fasting to maintain metabolic freedom without lifelong dependency. True success means labs stay optimal even after tapering off the medication.

Building Metabolic Freedom Beyond the Medication

The biggest mistake I see is treating these drugs as permanent crutches. Our protocol removes grains, lectins, and toxins while rebuilding hunger signals and mitochondrial function. Patients following the exact 221 recipes and Detox Drops protocol consistently show normalized inflammatory markers and sustained 30-90 lb losses. Focus on non-scale victories—energy, joint pain relief, medication reduction—rather than chasing perfect numbers. If your labs concern you, share them with a provider familiar with our cycling method. The goal is metabolic reset, not medication forever.